Biohaven

is a Connecticut-based pharmaceutical company that researches and develops novel drugs for the treatment of neurological and neuropsychiatric diseases...
Read more
Biohaven CEO: Vlad Coric

CEO

Vlad Coric

CEO Approval Rating

92/100

2013

28362834 NAICS listing
Est. Annual Revenue
$500M-1.0B
Agree?
Est. Employees
500-1.0K
Agree?
Funding
$748.3M
Acquisitions
2
Investments
1

Biohaven Competitors

1Covis Pharma
2Neuropore Therapies
3MODAG
4ProMIS Neurosciences
5Dart NeuroScience
6Allergan
7Zosano Pharma
8Denali
9Alector
10Alzheon
See 13+ competitors

Trending Companies